James V. Caruso
CIK: 0001202770
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Cellectar Biosciences, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jul 7, 2026CLRB
Cellectar Biosciences, Inc.
Award(A)DirectStock option (right to buy)
250K shares- - May 7, 2026CLRB
Cellectar Biosciences, Inc.
Purchase(P)Direct8.7K shares at avg. $2.88$25K - Jul 2, 2025CLRB
Cellectar Biosciences, Inc.
Purchase(P)Direct10K shares at avg. $4.99$50K - Feb 14, 2025CLRB
Cellectar Biosciences, Inc.
Award(A)DirectStock option (right to buy)
900K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 7, 2026 | CLRB Cellectar Biosciences, Inc. | Award(A) Stock option (right to buy) | 250,000 | - | - | Direct |
| May 7, 2026 | CLRB Cellectar Biosciences, Inc. | Purchase(P) | 8,680 | $2.88 | $24,998 | Direct |
| Jul 2, 2025 | CLRB Cellectar Biosciences, Inc. | Purchase(P) | 10,000 | $4.99 | $49,900 | Direct |
| Feb 14, 2025 | CLRB Cellectar Biosciences, Inc. | Award(A) Stock option (right to buy) | 900,000 | - | - | Direct |
1-4 of 4 transactions
About CARUSO JAMES V
CARUSO JAMES V (SEC CIK 0001202770) files insider reports with the SEC as President & CEO of Cellectar Biosciences, Inc. (CLRB).
Signal8 holds 4 ownership filings by CARUSO JAMES V, all Form 4s, filed between Feb 18, 2025 and Jul 8, 2026. Those filings report 4 transactions, from Feb 14, 2025 to Jul 7, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on CARUSO JAMES V's filings is in FLORHAM PARK, NJ.
Recent filings by CARUSO JAMES V
Other insiders filing for Cellectar Biosciences, Inc. (CLRB)
- Loren Stefan, Officer
- Kolean Chad J, CFO
- DRISCOLL FREDERICK W, Director
- Chanan-Khan Asher, Director
- Gu Andrew, Director
- Longcor Jarrod, Chief Operating Officer